The study team screened its first participant for the DaDHS trial of doxycycline as pre-exposure prophylaxis against syphilis and other bacterial sexually transmitted infections today. Congratulations to study coordinator Reva Persaud for launching the trial! Read more about the trial here.
Recent Comments